Recently, the 18th Annual Academic Meeting of the World Federation of Chinese Medicine Societies (WFCMS) Clinical Efficacy Evaluation Professional Committee, the 8th International Forum on Evidence-Based TCM, and the 4th International Forum on TCM Core Indicators were held in Rome, Italy. Zhang Boli, Honorary President of Tianjin University of TCM and Vice Chairman of WFCMS, stated that the key to TCM inheritance and innovative development lies in efficacy. Developing evaluation methods aligned with TCM efficacy characteristics and scientifically assessing TCM's efficacy advantages is a critical task for the high-quality development of TCM. To enhance TCM clinical evaluation, it is necessary to continuously deepen evidence-based practice and methodological innovation, strengthen the scientific understanding of TCM mechanisms...
